Skip to content
Catalyst
Plasma phenylalanine concentration

1 finding · 1 compound · by evidence strength. No dose is advised.

Fig. 2 Plasma phenylalanine concentration1 compound Selected Plasma phenylalanine concentration · centre
×1.60
Labels
Measured outcomeInspector

Plasma phenylalanine concentration

Findings drawn, by strength

1finding · 1 compound

  • Very limited1
Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

Compound lowersFindingsStrongest
1
Very limited

Not pooled · no summary effect · point at a mark · Tab, then the arrow keys

Reported to move it1 finding

  1. L-threonineMoved: lowersEvidence: Very limitedPaper: PMID 124999922003
    Who
    Patients with hyperphenylalaninemia, placebo-controlled crossover (8 weeks supplement, 8 weeks wash-out, 8 weeks crossed over), on special PHE-free amino acid mixture diets
    Dose studied
    oral L-threonine (THR), approximately 50 mg/kg per day for 8 weeks, against a similar amount of maltodextrin as placebo

    Dietary THR supplementation of approximately 50 mg/kg per day resulted in a significant decrease of plasma PHE levels ( P = 0.0234).”

    Quoted verbatim from Dietary threonine reduces plasma phenylalanine levels in patients with hyperphenylalaninemia.crossover · 8 weeksPermalink

How it is measured

Concentration of phenylalanine in plasma, serum or a dried blood spot, by amino-acid analyser, HPLC, tandem mass spectrometry or an enzymatic assay, fasting or at stated times after a load. The matrix, the assay and the sampling time are recorded with each finding.

Papers about it

As an endpoint1

Show the paperHide the paper
  • Dietary threonine reduces plasma phenylalanine levels in patients with hyperphenylalaninemia.

    Journal of pediatric gastroenterology and nutrition2003PMID 12499992Via: named in the paper, as read